INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단 FILES APPLICATION FOR "DISEASE-SPECIFIC EPIGENETIC BIOMARKER FOR DIAGNOSING EDWARD SYNDROME AND USE THEREOF"

GENEVA, March 25 -- SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566) filed a patent application (PCT/KR2023/021934) for "DISEASE-SPECIFIC EPIGENETIC BIOMARKER FOR DIAGNOSING EDWARD SYNDROME AND USE THEREOF" on Dec 28, 2023. With publication no. WO/2025/058140, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RYU, Hyun Mee (16 Y...